| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |